Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Community-acquired CTX-M-15-type ESBL-producing Escherichia coli meningitis: a case report and literature review.

Elaldi N, Gozel MG, Kolayli F, Engin A, Celik C, Bakici MZ, Vahaboglu H.

J Infect Dev Ctries. 2013 May 13;7(5):424-31. doi: 10.3855/jidc.2820. Review.

2.

Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases.

Calbo E, Romaní V, Xercavins M, Gómez L, Vidal CG, Quintana S, Vila J, Garau J.

J Antimicrob Chemother. 2006 Apr;57(4):780-3. Epub 2006 Feb 21.

PMID:
16492721
3.

The emergence and dissemination of CTX-M-producing Escherichia coli sequence type 131 causing community-onset bacteremia in Israel.

Karfunkel D, Carmeli Y, Chmelnitsky I, Kotlovsky T, Navon-Venezia S.

Eur J Clin Microbiol Infect Dis. 2013 Apr;32(4):513-21. doi: 10.1007/s10096-012-1765-9. Epub 2012 Nov 2.

PMID:
23117265
4.
5.
6.

CTX-M type extended spectrum beta-lactamases in Escherichia coli isolates from community acquired upper urinary tract infections at a university in the European part of Turkey.

Celik AD, Yulugkural Z, Kuloglu F, Eroglu C, Torol S, Vahaboğlu H, Akata F.

J Microbiol Immunol Infect. 2010 Apr;43(2):163-7. doi: 10.1016/S1684-1182(10)60026-6.

7.

First initial community-acquired meningitis due to extended-spectrum beta-lactamase producing Escherichia coli complicated with multiple aortic mycotic aneurysms.

Weyrich P, Ettahar N, Legout L, Meybeck A, Leroy O, Senneville E.

Ann Clin Microbiol Antimicrob. 2012 Feb 9;11:4. doi: 10.1186/1476-0711-11-4.

8.

Mecillinam/clavulanate combination: a possible option for the treatment of community-acquired uncomplicated urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli.

Lampri N, Galani I, Poulakou G, Katsarolis I, Petrikkos G, Giamarellou H, Souli M.

J Antimicrob Chemother. 2012 Oct;67(10):2424-8. doi: 10.1093/jac/dks215. Epub 2012 Jun 4.

PMID:
22665388
9.

CTX-M-producing Escherichia coli in a maternity ward: a likely community importation and evidence of mother-to-neonate transmission.

Dubois V, De Barbeyrac B, Rogues AM, Arpin C, Coulange L, Andre C, M'zali F, Megraud F, Quentin C.

J Antimicrob Chemother. 2010 Jul;65(7):1368-71. doi: 10.1093/jac/dkq153. Epub 2010 May 13.

PMID:
20466850
10.

Epidemiology and risk factors of community onset infections caused by extended-spectrum β-lactamase-producing Escherichia coli strains.

Kang CI, Wi YM, Lee MY, Ko KS, Chung DR, Peck KR, Lee NY, Song JH.

J Clin Microbiol. 2012 Feb;50(2):312-7. doi: 10.1128/JCM.06002-11. Epub 2011 Dec 7.

11.

In vitro activity of beta-lactam antibiotics against CTX-M-producing Escherichia coli.

Tärnberg M, Ostholm-Balkhed A, Monstein HJ, Hällgren A, Hanberger H, Nilsson LE.

Eur J Clin Microbiol Infect Dis. 2011 Aug;30(8):981-7. doi: 10.1007/s10096-011-1183-4. Epub 2011 Feb 6.

PMID:
21298459
12.

Activity of ertapenem and other antimicrobials against ESBL-producing enterobacteria isolated from urine in patients from Madrid.

Tamayo J, Orden B, Cacho J, Cuadros J, Gomez-Garces JL, Alos JI.

Rev Esp Quimioter. 2007 Sep;20(3):334-8.

13.

CTX-M-producing Escherichia coli and Klebsiella pneumoniae isolated from community-acquired urinary tract infections in Valledupar, Colombia.

Martinez P, Garzón D, Mattar S.

Braz J Infect Dis. 2012 Sep-Oct;16(5):420-5. doi: 10.1016/j.bjid.2012.05.001. Epub 2012 Sep 8.

14.

Proportion of extended-spectrum ß-lactamase-producing Enterobacteriaceae in community setting in Ngaoundere, Cameroon.

Lonchel CM, Meex C, Gangoué-Piéboji J, Boreux R, Assoumou MC, Melin P, De Mol P.

BMC Infect Dis. 2012 Mar 9;12:53. doi: 10.1186/1471-2334-12-53.

15.

Turkey: a further country concerned by community-acquired Escherichia coli clone O25-ST131 producing CTX-M-15.

Yumuk Z, Afacan G, Nicolas-Chanoine MH, Sotto A, Lavigne JP.

J Antimicrob Chemother. 2008 Aug;62(2):284-8. doi: 10.1093/jac/dkn181. Epub 2008 May 2.

PMID:
18453527
16.

[Case of an elderly patient with community acquired bacterial meningitis due to extended spectrum β lactamase producing Escherichia coli].

Gon Y, Otsubo R, Murase S, Park K, Nakazawa K, Hara H.

Rinsho Shinkeigaku. 2012;52(1):12-8. Review. Japanese.

PMID:
22260973
17.

Clinical and molecular epidemiology of community-onset, extended-spectrum beta-lactamase-producing Escherichia coli infections in Thailand: a case-case-control study.

Apisarnthanarak A, Kiratisin P, Saifon P, Kitphati R, Dejsirilert S, Mundy LM.

Am J Infect Control. 2007 Nov;35(9):606-12.

PMID:
17980240
18.

Prevalence of rectal carriage of extended-spectrum beta-lactamase-producing Escherichia coli among elderly people in community settings in China.

Tian SF, Chen BY, Chu YZ, Wang S.

Can J Microbiol. 2008 Sep;54(9):781-5. doi: 10.1139/w08-059.

PMID:
18772941
19.

Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.

Mendonça N, Leitão J, Manageiro V, Ferreira E, Caniça M.

Antimicrob Agents Chemother. 2007 Jun;51(6):1946-55. Epub 2007 Mar 19.

20.

ESBL-producing Escherichia coli isolated from children with acute diarrhea - antimicrobial susceptibility, adherence patterns and phylogenetic background.

Franiczek R, Sobieszczańska B, Turniak M, Kasprzykowska U, Krzyzanowska B, Jermakow K, Mokracka-Latajka G.

Adv Clin Exp Med. 2012 Mar-Apr;21(2):187-92.

Supplemental Content

Support Center